• Something wrong with this record ?

Exosomal miR-126 as a circulating biomarker in non-small-cell lung cancer regulating cancer progression

F. Grimolizzi, F. Monaco, F. Leoni, M. Bracci, S. Staffolani, C. Bersaglieri, S. Gaetani, M. Valentino, M. Amati, C. Rubini, F. Saccucci, J. Neuzil, M. Tomasetti, L. Santarelli,

. 2017 ; 7 (1) : 15277. [pub] 20171110

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc19035535

Lung cancer is one of the leading causes of cancer-related deaths. It is diagnosed mostly at the locally advanced or metastatic stage. Recently, micro RNAs (miRs) and their distribution in circulation have been implicated in physiological and pathological processes. In this study, miR-126 was evaluated in serum, exosome and exosome-free serum fractions in non-small cell lung cancer (NSCLC) patients at early and advanced stages, and compared with healthy controls. Down-regulation of miR-126 was found in serum of advanced stage NSCLC patients. In healthy controls, circulating miR-126 was equally distributed between exosomes and exosome-free serum fractions. Conversely, in both early and advanced stage NSCLC patients, miR-126 was mainly present in exosomes. Different fractions of miR-126 in circulation may reflect different conditions during tumour formation. Incubation of exosomes from early and advanced NSCLC patients induced blood vessel formation and malignant transformation in human bronchial epithelial cells. On the other hand, exosome-enriched miR-126 from normal endothelial cells inhibited cell growth and induces loss of malignancy of NSCLC cells. These findings suggest a role of exo-miRs in the modulation of the NSCLC microenvironmental niche. Exosome-delivered miRs thus hold a substantial promise as a diagnostics biomarker as well as a personalized therapeutic modality.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19035535
003      
CZ-PrNML
005      
20191008113043.0
007      
ta
008      
191007s2017 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41598-017-15475-6 $2 doi
035    __
$a (PubMed)29127370
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Grimolizzi, Franco $u Department of Clinical Sciences, Section of Biochemistry, Biology and Physics, Via Tronto 10/a, 60020, Ancona, Italy.
245    10
$a Exosomal miR-126 as a circulating biomarker in non-small-cell lung cancer regulating cancer progression / $c F. Grimolizzi, F. Monaco, F. Leoni, M. Bracci, S. Staffolani, C. Bersaglieri, S. Gaetani, M. Valentino, M. Amati, C. Rubini, F. Saccucci, J. Neuzil, M. Tomasetti, L. Santarelli,
520    9_
$a Lung cancer is one of the leading causes of cancer-related deaths. It is diagnosed mostly at the locally advanced or metastatic stage. Recently, micro RNAs (miRs) and their distribution in circulation have been implicated in physiological and pathological processes. In this study, miR-126 was evaluated in serum, exosome and exosome-free serum fractions in non-small cell lung cancer (NSCLC) patients at early and advanced stages, and compared with healthy controls. Down-regulation of miR-126 was found in serum of advanced stage NSCLC patients. In healthy controls, circulating miR-126 was equally distributed between exosomes and exosome-free serum fractions. Conversely, in both early and advanced stage NSCLC patients, miR-126 was mainly present in exosomes. Different fractions of miR-126 in circulation may reflect different conditions during tumour formation. Incubation of exosomes from early and advanced NSCLC patients induced blood vessel formation and malignant transformation in human bronchial epithelial cells. On the other hand, exosome-enriched miR-126 from normal endothelial cells inhibited cell growth and induces loss of malignancy of NSCLC cells. These findings suggest a role of exo-miRs in the modulation of the NSCLC microenvironmental niche. Exosome-delivered miRs thus hold a substantial promise as a diagnostics biomarker as well as a personalized therapeutic modality.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a nádorové biomarkery $x krev $7 D014408
650    _2
$a nemalobuněčný karcinom plic $x krev $x patologie $7 D002289
650    _2
$a cirkulující mikroRNA $x krev $7 D000074166
650    _2
$a exozómy $x metabolismus $x patologie $7 D055354
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a nádory plic $x krev $x patologie $7 D008175
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mikro RNA $x krev $7 D035683
650    _2
$a lidé středního věku $7 D008875
650    _2
$a RNA nádorová $x krev $7 D012334
650    _2
$a nádorové mikroprostředí $7 D059016
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Monaco, Federica $u Department of Clinical and Molecular Sciences, Section of Occupational Medicine, Via Tronto 10/a, 60020, Ancona, Italy.
700    1_
$a Leoni, Francesca $u Department of Clinical Sciences, Section of Biochemistry, Biology and Physics, Via Tronto 10/a, 60020, Ancona, Italy.
700    1_
$a Bracci, Massimo $u Department of Clinical and Molecular Sciences, Section of Occupational Medicine, Via Tronto 10/a, 60020, Ancona, Italy.
700    1_
$a Staffolani, Sara $u Department of Clinical and Molecular Sciences, Section of Occupational Medicine, Via Tronto 10/a, 60020, Ancona, Italy.
700    1_
$a Bersaglieri, Cristiana $u Department of Clinical and Molecular Sciences, Section of Occupational Medicine, Via Tronto 10/a, 60020, Ancona, Italy.
700    1_
$a Gaetani, Simona $u Department of Clinical and Molecular Sciences, Section of Occupational Medicine, Via Tronto 10/a, 60020, Ancona, Italy.
700    1_
$a Valentino, Matteo $u Department of Clinical and Molecular Sciences, Section of Occupational Medicine, Via Tronto 10/a, 60020, Ancona, Italy.
700    1_
$a Amati, Monica $u Department of Clinical and Molecular Sciences, Section of Occupational Medicine, Via Tronto 10/a, 60020, Ancona, Italy.
700    1_
$a Rubini, Corrado $u Department of Biomedical Sciences and Public Health, Section of Anatomical Pathology, Polytechnic University of Marche, Via Tronto 10/a, 60020, Ancona, Italy.
700    1_
$a Saccucci, Franca $u Department of Clinical Sciences, Section of Biochemistry, Biology and Physics, Via Tronto 10/a, 60020, Ancona, Italy.
700    1_
$a Neuzil, Jiri $u School of Medical Science, Griffith University, Southport, Qld, 4222, Australia. Institute of Biotechnology, Czech Academy of Sciences, Prague-West, 25242, Czech Republic.
700    1_
$a Tomasetti, Marco $u Department of Clinical and Molecular Sciences, Section of Occupational Medicine, Via Tronto 10/a, 60020, Ancona, Italy. m.tomasetti@univpm.it.
700    1_
$a Santarelli, Lory $u Department of Clinical and Molecular Sciences, Section of Occupational Medicine, Via Tronto 10/a, 60020, Ancona, Italy. l.santarelli@univpm.it.
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 7, č. 1 (2017), s. 15277
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29127370 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20191007 $b ABA008
991    __
$a 20191008113459 $b ABA008
999    __
$a ok $b bmc $g 1452195 $s 1074085
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 7 $c 1 $d 15277 $e 20171110 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
LZP    __
$a Pubmed-20191007

Find record

Citation metrics

Archiving options